Zevra Therapeutics Inc.

ZVRA · Moat type: REGULIERUNG

MoatScore

6/10

Fair Value

38 USD

Margin of Safety

+66.1 %

Rating

BEOBACHTEN

GESCHÄFTSMODELL Zevra Therapeutics is a U.S. biotechnology company specialized in rare diseases that generates commercial revenues from approved drugs for orphan disease indications, supplemented by a pipeline royalty and licensing strategy.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.